How AI Discovered a New Antibiotic to Combat Deadly Superbugs

Revolutionizing Medicine - How AI Discovered a New Antibiotic to Combat Deadly Superbugs. Artificial Intelligence looked at 6,680 molecules in about less than two hours to find 240 that were likely to kill a superbug bacteria, resistant to other antibacterial drugs. Why will it take 10 years of clinical trials? Covid vaccines were put on the fast track and they killed 20 million people. This antibacterial should be used in emergency cases, just as the vaccine that turned out to be a bioweapon. The drug could help to combat Acinetobacter baumannii, a species of bacteria that is often found in hospitals and can lead to pneumonia, meningitis, and other serious infections. Abaucin is the killer of resistant bacteria.
"This finding further supports the premise that AI can significantly accelerate and expand our search for novel antibiotics," says James Collins, the Termeer Professor of Medical Engineering and Science in MIT's Institute for Medical Engineering and Science (IMES) and Department of Biological Engineering. "I'm excited that this work shows that we can use AI to help combat problematic pathogens such as A. baumannii."